Overview

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the imaging feasibility and safety of 212Pb-NG001.
Phase:
Early Phase 1
Details
Lead Sponsor:
ARTBIO Inc.